AFM
TRAW icon

Anson Funds Management’s Traws Pharma TRAW Stock Holding History

Anson Funds Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,812
Closed -$370K – 441
2021
Q4 		$370K Buy
+5,812
New +$467K 0.04% 263
2016
Q2 		– Sell
-11
Closed -$367K – 74
2016
Q1 		$367K Buy
+11
New +$349K 0.05% 55
2015
Q1 		– Sell
-1
Closed -$165K – 66
2014
Q4 		$165K Buy
+1
New +$245K 0.2% 66

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Anson Funds Management's TRAW Position: Q1 2022 in Review

Anson Funds Management sold out of Traws Pharma (TRAW) in Q1 2022, closing a stake of 5,812 shares — an estimated $370K sold.

Anson Funds Management first reported a position in TRAW in Q4 2014 and held it in 3 quarters. The position peaked at $370K in Q4 2021. 30 funds tracked by Wall St. Rank hold TRAW as of Q1 2022.

  • Anson Funds Management reported no remaining Traws Pharma position as of Q1 2022 after selling out during the quarter.
  • Anson Funds Management sold 5,812 Traws Pharma shares in Q1 2022, an estimated $370K.
  • Anson Funds Management first reported a position in Traws Pharma in Q4 2014 and held it in 3 quarters.
  • Anson Funds Management's Traws Pharma position peaked at $370K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2022.

Based on Anson Funds Management's 13F filing for Q1 2022, filed 12 May 2022.